tiletamine hydrochloride has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Listing, J; Manger, B; Meissner, Y; Richter, A; Strangfeld, A; Tony, HP; Wilden, E; Zink, A | 1 |
| Champion, HC; Harris, ZL; Santhanam, L; Shoukas, AA; Thompson-Torgerson, CS | 1 |
2 other study(ies) available for tiletamine hydrochloride and Cardiovascular Diseases
| Article | Year |
|---|---|
Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort.
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Case-Control Studies; Cyclohexanones; Female; Germany; Humans; Hypolipoproteinemias; Immunocompromised Host; Incidence; Infections; Ischemic Attack, Transient; Male; Middle Aged; Phenols; Proportional Hazards Models; Registries; Risk Factors; Smoking; Stroke | 2017 |
Cyclohexanone contamination from extracorporeal circuits impairs cardiovascular function.
Topics: Animals; Baroreflex; Cardiovascular Diseases; Crystalloid Solutions; Cyclohexanones; Edema; Extracorporeal Circulation; Gas Chromatography-Mass Spectrometry; Heart Diseases; Heart Rate; Hypertension, Pulmonary; Hypotension; Infusions, Intravenous; Isotonic Solutions; Male; Myocardial Contraction; Plastics; Rats; Rats, Sprague-Dawley; Solvents; Stroke Volume; Vascular Resistance; Vasoconstriction | 2009 |